Andrew Ritter, CEO & President, Director at Qualigen Therapeutics, holds 82.35K shares in Qualigen Therapeutics (Ticker: QLGN). Most recently, Andrew Ritter Sold $18,750 shares of Qualigen Therapeutics on Mar 13, 2020 for an estimated value of 6.94K.
What is the percentage of profitable transactions made by Andrew Ritter?
The percentage of profitable transactions made by Andrew Ritter is 100%.
What is the average return per transaction made by Andrew Ritter?
The average return per transaction made by Andrew Ritter is 64.20%.
What stocks does Andrew Ritter hold?
Andrew Ritter holds: QLGN stocks.
What was Andrew Ritter’s latest transaction?
Andrew Ritter latest transaction was an Informative Sell of $6.94K.
What was Andrew Ritter's most profitable transaction?
Andrew Ritter’s most profitable transaction was an Informative Buy of QLGN stock on February 24, 2016. The return on the trade was 86.40%.
What is Andrew Ritter's role in Qualigen Therapeutics?
Andrew Ritter's role in Qualigen Therapeutics is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.